Association between transforming growth factor-β₁gene-509C/T polymorphism and susceptibility of IgA nephropathy: a meta-analysis

References

• Strippoli GF, Maione A, Schena FP, Tognoni G, Craig JC. IgA nephropathy: A disease in search of a large-scale clinical trial to reliably inform practice. Am J Kidney Dis. 2009;53:5–8
   Google Scholar
• Barratt J, Eitner F, Feehally J, Floege J. Immune complex formation in IgA nephropathy: A case of the ‘right' antibodies in the ‘wrong' place at the ‘wrong' time? Nephrol Dial Transplant. 2009;24:3620–3623
   Google Scholar
• Glassock RJ. IgA nephropathy: Challenges and opportunities. Cleve Clin J Med. 2008;75:569–576
   Google Scholar
• Amoroso L, De Sanctis L, Cappelli P, et al. Management of IgA nephropathy. G Ital Nefrol. 2011;28:622–632
   Google Scholar
• Wyatt R, Julian B. IgA nephropathy. N Engl J Med. 2013;368:2402–2414
   PubMed Web of Science ®Google Scholar
• Kalliakmani P, Nakopoulou L, Tsakas S, et al. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-beta) levels in corticosteroid treated patients with IgA nephropathy. Clin Nephrol. 2011;76:144–150
   Google Scholar
• Lepenies J, Eardley KS, Kienitz T, et al. Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-beta(1) in patients with chronic kidney disease. Nephron Clin Pract. 2011;119:97–104
   PubMed Web of Science ®Google Scholar
• Ito Y, Goldschmeding R, Kasuga H, et al. Expression patterns of connective tissue growth factor and of TGF-beta isoforms during glomerular injury recapitulate glomerulogenesis. Am J Physiol Renal Physiol. 2009;299:545–558
   Google Scholar
• Brabcova I, Tesar V, Honsova E, et al. Association of advanced vasculopathy and transforming growth factor-beta1 gene expression with immunoglobulin A nephropathy progression. Nephrol Dial Transplant. 2011;26:573–579
   PubMedGoogle Scholar
• Wang C, Liu X, Peng H, et al. Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation. Arch Med Res. 2010;41:255–260
   Google Scholar
• Ye XF, Yorioka N, Oda H, Taniguchi Y, Yamakido M. Role of intercellular adhesion molecule-1, lymphocyte function-associated antigen-1, and macrophages in ddY mouse nephropathy. Hiroshima J Med Sci. 1997;46:75–80
   Google Scholar
• Border WA, Okuda S, Nakamura T, Languino LR, Ruoslahti E. Role of TGF-beta 1 in experimental glomerulonephritis. Ciba Found Symp. 1991;157:178–193
   Google Scholar
• Braga M, Bhasin S, Jasuja R, Pervin S, Singh, R. Testosterone inhibits transforming growth factor-beta signaling during myogenic differentiation and proliferation of mouse satellite cells: Potential role of follistatin in mediating testosterone action. Mol Cell Endocrinol. 2002;350:39–52
   Google Scholar
• Mi XH, Luan S, Ma XY, et al. Effects of Artesunate on MCP-1 and MCP-1 mRNA expression of renal tissue in the rat IgA nephropathy model. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009;40:821–825
   Google Scholar
• Buckova D, Izakovicova HL, Benes P, Znojil V, Vacha J. TGF-beta1 gene polymorphisms. Allergy. 2001;56:1236–1237
   PubMed Web of Science ®Google Scholar
• Valladares-Salgado A, Angeles-Martinez J, Rosas M, et al. Association of polymorphisms within the transforming growth factor-beta1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations. Nephrology (Carlton). 2010;15:644–648
   PubMed Web of Science ®Google Scholar
• Lim CS, Kim YS, Chae DW, et al. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin Nephrol. 2005;63:61–67
   PubMedGoogle Scholar
• Li Y, Liu FY, Peng YM, et al. the relationship between the TGF-beta1 gene −509C/T polymorphism and tubulointerstitial damage resulting from primary nephrotic syndrome. Ren Fail. 2010;32:420–427
   PubMed Web of Science ®Google Scholar
• Chootrakool H, Shi JQ, Yue R. Meta-analysis and sensitivity analysis for multi-arm trials with selection bias. Stat Med. 2001;30:1183–1198
   Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
   PubMed Web of Science ®Google Scholar
• DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med. 1996;15:1237–1252
   PubMed Web of Science ®Google Scholar
• Shi-liang Li, Lin-Xu, Jie Wang. Relationship of transforming growth factor β1 gene-509C/T polymorphism with IgA nephropathy in Western Guangxi. China J Modern Med. 2011;21:1607–1610
   Google Scholar
• Qin Wei, Zhang Ying-Juan, Tan Chun-Yu. Association of TGF-β1 gene polymorphism with IgA nephropathy. West China Med J. 2008;23:65–69
   Google Scholar
• Xue Chao, Li You-Ji, Li Cai-Xia. Relationship of TGFβ1-509C/T polymorphism with IgA nephropathy in Han Nationality of Chinese population. J Sun Yat-Sen Univ (Medical Sciences). 2005;26:261–263
   Google Scholar
• Lim CS, Kim YS, Chae DW, et al. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin Nephrol. 2005;63:61–67
   PubMedGoogle Scholar
• Vuong MT, Lundberg S, Gunnarsson I, et al. Genetic variation in the transforming growth factor-beta1 gene is associated with susceptibility to IgA nephropathy. Nephrol Dial Transplant. 2009;24:3061–3067
   PubMedGoogle Scholar
• Sato F, Narita I, Goto S, et al. Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Tissue Antigens. 2004;64:35–42
   PubMedGoogle Scholar
• Brezzi B, Del PD, Lupo A, et al. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. J Nephrol. 2009;22:747–759
   PubMedGoogle Scholar
• Kim SK, Lee JY, Jeong P, et al. Association between lymphotoxin Beta receptor gene polymorphisms and IgA nephropathy in Korean children. Immunol Invest. 2012;41:447–457
   PubMed Web of Science ®Google Scholar
• Woo KT, Lau YK, Chan CM, et al. ACE gene sequence and nucleotide variants in IgA nephropathy. Singapore Med J. 2011;52:824–834
   Google Scholar
• Bantis C, Heering PJ, Siekierka-Harreis M, et al. Impact of aldosterone synthase gene C-344T polymorphism on IgA nephropathy. Ren Fail. 2011;33:393–397
   PubMed Web of Science ®Google Scholar
• Lee JS, Suh KT, Kim JI, Lim JM, Goh TS. Association of estrogen receptor gene polymorphism in patients with degenerative lumbar spondylolisthesise. J Korean Neurosurg Soc. 2011;50:415–419
   Google Scholar
• Woo KT, Lau YK, Zhao Y, et al. Urotensin 2 and retinoic acid receptor alpha (RARA) gene expression in IgA nephropathy. Ann Acad Med Singapore. 2010;39:705–709
   Google Scholar